ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,812Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 1448

$1.15M Total Retail Price of All Prescriptions

Rank: 21 out of 1448

1,157 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 1,157 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

20% of this provider’s 1,157 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

3% of this provider’s 17,521 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 1,080 772 S3 1 33
SIMVASTATIN 895 766 2 3
LEVOTHYROXINE SODIUM 886 805 3 21
OMEPRAZOLE 626 522 4 23
LISINOPRIL 544 479 5 5
ATENOLOL 480 428 6 12
GABAPENTIN 460 358 7 51
TRAMADOL HCL 388 315 8 56
METFORMIN HCL 365 330 9 25
METOPROLOL TARTRATE 334 293 10 9
LOVASTATIN 305 290 11 35
AMLODIPINE BESYLATE 296 277 12 2
METOPROLOL SUCCINATE 287 233 13 6
HYDROCHLOROTHIAZIDE 274 241 14 18
FUROSEMIDE 272 233 15 7
ZOLPIDEM TARTRATE 269 161 16 34
FLUOXETINE HCL 266 213 17 164
TRIAMTERENE-HCTZ 258 211 18 55
PAROXETINE HCL 252 213 19 121
BENAZEPRIL HCL 248 219 20 26
POTASSIUM CHLORIDE 247 168 21 19
CARVEDILOL 245 233 22 1
LOSARTAN POTASSIUM 224 207 23 11
ATORVASTATIN CALCIUM 217 199 24 4
FLUTICASONE PROPIONATE 217 172 24 130
TAMSULOSIN HCL 203 185 26 46
WARFARIN SODIUM 199 171 27 8
SERTRALINE HCL 194 156 28 99
SPIRIVA 193 172 29 97
LOSARTAN-HYDROCHLOROTHIAZIDE 183 161 30 38
ISOSORBIDE MONONITRATE ER 159 159 31 16
AZITHROMYCIN 151 83 32 76
CYMBALTA 148 75 33 123
ALPRAZOLAM 147 113 34 235
PROAIR HFA 144 121 35 104
ADVAIR DISKUS 141 105 36 74
ALENDRONATE SODIUM 139 129 37 41
GLIPIZIDE 136 133 38 75
PREDNISONE 128 82 39 110
SYMBICORT 118 98 40 208
CITALOPRAM HBR 117 63 41 129
TRAZODONE HCL 116 59 42 128
ESTRADIOL 116 76 R 42 198
LISINOPRIL-HYDROCHLOROTHIAZIDE 113 111 44 79
GLYBURIDE 112 95 R 45 89
TIZANIDINE HCL 112 73 45 317
LORAZEPAM 109 101 47 254
BUPROPION XL 109 61 47 284
TEMAZEPAM 106 80 49 229
GLIMEPIRIDE 106 101 49 66
ALLOPURINOL 106 100 49 43
MELOXICAM 101 45 52 73
RANITIDINE HCL 99 77 53 109
BENAZEPRIL-HYDROCHLOROTHIAZIDE 99 81 53 182
DONEPEZIL HCL 99 95 53 68
FAMOTIDINE 99 86 53 60
GEMFIBROZIL 97 93 57 127
IBUPROFEN 95 59 58 85
OXYBUTYNIN CHLORIDE 93 72 59 210
CLOPIDOGREL 92 87 60 10
DIGOXIN 90 85 61 13
INSULIN SYRINGE 89 84 62 139
BACLOFEN 88 29 63 166
FENTANYL 87 43 S2 64 284
PREMARIN 86 84 R 65 258
ACTOS 86 77 65 92
JANUVIA 86 86 65 64
OXYCODONE HCL-ACETAMINOPHEN 86 77 S2 65 288
PROMETHAZINE HCL 85 19 R 69 209
AMITRIPTYLINE HCL 84 58 R 70 153
CARISOPRODOL 83 44 R 71 176
ENALAPRIL MALEATE 82 63 72 48
CIPROFLOXACIN HCL 81 62 73 137
TERAZOSIN HCL 81 78 73 116
PRAVASTATIN SODIUM 79 56 75 20
ACETAMINOPHEN-CODEINE 75 60 S3 76 113
PANTOPRAZOLE SODIUM 73 61 77 42
TRIAMCINOLONE ACETONIDE 73 62 77 96
MORPHINE SULFATE ER 71 30 S2 79 275
CLONIDINE HCL 70 58 80 45
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 62 80 151
PHENYTOIN SODIUM EXTENDED 66 59 82 262
NAMENDA 62 58 83 93
CYCLOBENZAPRINE HCL 62 34 R 83 214
DIOVAN 61 60 85 15
NIFEDIPINE ER 60 49 86 59
HYDROMORPHONE HCL 59 14 S2 87 278
CEPHALEXIN 58 49 88 138
VERAPAMIL ER 56 54 89 88
PLAVIX 54 48 90 14
LANTUS 53 43 91 111
TRIAMTERENE-HYDROCHLOROTHIAZID 52 41 92 156
KLOR-CON 10 52 51 92 102
AMOXICILLIN 51 44 94 142
AVODART 50 49 95 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.